ROSUASIT GOLD, a triple-combination therapy meticulously designed to provide comprehensive cardioprotection and manage high-risk cardiovascular conditions.
ROSUASIT GOLD is a single-capsule formulation combining three powerful, clinically proven medications: Rosuvastatin, Clopidogrel, and Aspirin. This synergy offers a robust defense against major adverse cardiac events, reflecting Asitanila Remedies\\\' commitment to innovative and effective cardiovascular care.
Product Features
ROSUASIT GOLD is crafted to simplify high-risk cardiovascular management while maximizing therapeutic efficacy.
· Integrated Triple Therapy: Combines three critical cardioprotective agents into one capsule, significantly improving patient adherence (compliance) by reducing the pill burden.
· Comprehensive Risk Reduction: Targets the three primary risk factors for heart attacks and strokes: high cholesterol (Rosuvastatin), platelet aggregation (Aspirin), and thrombosis (Clopidogrel).
· Potent Lipid Management: Contains Rosuvastatin, recognized for its high efficacy in achieving target LDL-C levels, a crucial factor in atherosclerosis management.
· Simplified Treatment Regimen: Designed for convenient, once-daily dosing as prescribed by a healthcare professional, ensuring consistent therapeutic levels.
Indication: When is ROSUASIT GOLD Prescribed?
ROSUASIT GOLD is typically prescribed for patients who require combined therapy for the prevention of cardiovascular events. This often includes:
1. Post-Percutaneous Coronary Intervention (PCI): Following stent placement.
2. Acute Coronary Syndrome (ACS): After a heart attack or unstable angina.
3. Established Cardiovascular Disease (CVD): Patients with a history of heart attack or stroke who require aggressive lipid and platelet management.
4. High-Risk Primary Prevention: Individuals with multiple co-morbidities (e.g., Diabetes, Hypertension) and high calculated cardiovascular risk
The Asitanila Commitment to Quality
Asitanila Remedies Private Limited ensures that ROSUASIT GOLD meets the highest standards of pharmaceutical manufacturing.